Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • MAP PHARMACEUTICALS INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 44.71 M 94.99 M 97.76 M 7.16 M 22.26 M
    Net Receivables 0.00 0.00 0.00 0.00 —
    Total Inventories 0.00 0.00 0.00 0.00 —
    Progress Payments & Others 0.00 0.00 0.00 0.00 —
    Prepaid Expenses — — — — —
    Other Current Assets 805,000.00 1.08 M 443,149.00 222,417.00 —
    Current Assets Total 45.52 M 96.07 M 98.20 M 7.38 M —
    Long Term Receivables 0.00 0.00 0.00 0.00 —
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 —
    Other Investments 310,000.00 321,000.00 200,370.00 200,370.00 —
    Property, Plant & Equipment Net 5.01 M 4.18 M 2.85 M 1.97 M —
    Property, Plant & Equipment Gross 8.04 M 6.01 M 3.83 M 2.38 M —
    Accumulated Depreciation 3.03 M 1.83 M 979,338.00 404,002.00 —
    Other Assets 28,000.00 122,000.00 383,019.00 215,875.00 —
    Deferred Charges — — — — —
    Tangible Other Assets 28,000.00 122,000.00 383,019.00 215,875.00 —
    Intangible Other Assets — — — — —
    Total Assets 50.86 M 100.70 M 101.63 M 9.77 M 23.91 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 6.35 M 3.82 M 840,369.00 — —
    Accrued Payroll 2.79 M 1.62 M 847,278.00 477,674.00 —
    Income Taxes Payable 0.00 0.00 0.00 0.00 —
    Dividends Payable 0.00 0.00 0.00 0.00 —
    Other Current Liabilities 12.65 M 6.00 M 1.48 M 1.71 M —
    Current Liabilities Total 23.42 M 12.73 M 4.93 M 3.27 M —
    Long Term Debt 14.23 M 6.36 M 410,988.00 0.00 —
    Provision for Risks & Charges 0.00 0.00 0.00 0.00 —
    Deferred Taxes 0.00 0.00 0.00 0.00 —
    Deferred Income — — — — —
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 60,000.00 0.00 0.00 0.00 —
    Total Liabilities 37.71 M 19.09 M 5.34 M 3.27 M —
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 —
    Minority Interest 0.00 0.00 0.00 0.00 —
    Preferred Stock 0.00 0.00 0.00 0.00 —
    Common Equity 13.15 M 81.61 M 96.29 M 6.50 M 22.67 M
    Common Stock 200,000.00 197,000.00 189,000.00 — —
    Capital Surplus 188.80 M 184.19 M 173.08 M — —
    Revaluation Reserves — — — — —
    Other Appropriated Reserves — — — — —
    Unappropriated (Free) Reserves — — — — —
    Retained Earnings -175.89 M -102.97 M -77.00 M — —
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees — — — — —
    Unrealized Foreign Exchange Gain (Loss) — — — — —
    Unrealized Gain (Loss) on Marketable Securities 44,000.00 181,000.00 16,000.00 — —
    Treasury Stock 0.00 0.00 0.00 — —
    Total Liabilities & Shareholders Equity 50.86 M 100.70 M 101.63 M 9.77 M 23.91 M
    Common Shares Outstanding 20.55 M 20.23 M 19.27 M 6.11 M 6.11 M